Thrombo Genics Nv

All the email addresses for thrombogenics.com

{first}.{last}@thrombogenics.com
31 email addresses
http://drugs.com/clinical_trials/thrombogenics-presents-new-exciting-microplasmin-phase-iii-data-world-ophthalmology-congress-woc-9542.html March 3, 2016
http://prnewswire.com/news-releases/thrombogenics-opens-new-us-headquarters-141445613.html March 3, 2016
http://bio-medicine.org/biology-technology-1/thrombogenics-announces-business-update-and-2008-full-year-results-10968-1 March 3, 2016
http://thestreet.com/story/11572038/2/thrombogenics-receives-notice-from-fda-of-advisory-committee-meeting-for-ocriplasmin.html January 1, 2015
http://bio-medicine.org/biology-technology-1/thrombogenics-and-bioinvent-receive-approval-to-begin-clinical-trials-of-tb-403-for-the-treatment-of-cancer-2648-4/ August 8, 2015
http://biospace.com/news/thrombogenics-nv-completes-private-placement/254729 January 1, 2015
http://drugs.com/clinical_trials/positive-results-phase-ii-vte-prophylaxis-study-tb-402-anti-factor-viii-presented-21st-9790.html March 3, 2016
http://biospace.com/news/bioinvent-and-thrombogenics-ltd-to-receive-eur-10/180707 July 7, 2017
http://au.sys-con.com/node/2464765 June 6, 2017
http://bio-medicine.org/medicine-technology-1/thrombogenics-completes-patient-enrolment-in-us-phase-iii-trial-of-microplasmin-for-the-non-surgical-treatment-of-eye-disease-5051-1 May 5, 2017
http://bio-medicine.org/biology-technology-1/thrombogenics---positive-microplasmin-phase-ii-data-published-in-ophthalmology-15547-1 May 5, 2017
http://thestreet.com/story/11893576/5/thrombogenics-jetrea-the-first-and-only-medicine-for-treating-vitreomacular-traction-now-launched-in-the-uk.html May 5, 2015
http://biospace.com/news_print.aspx May 5, 2015
http://thestreet.com/story/11776730/3/jetrea-selected-for-single-technology-appraisal-sta-by-the-uks-national-institute-for-health-and-clinical-excellence-nice.html April 4, 2015
http://it.sys-con.com/node/2500250 January 1, 2015
http://drugs.com/clinical_trials/bioinvent-thrombogenics-announce-positive-topline-results-phase-ii-vte-prophylaxis-study-anti-9358.html March 3, 2016
http://prnewswire.com/news-releases/us-fda-approves-thrombogenics-jetrea-ocriplasmin-for-the-treatment-of-symptomatic-vitreomacular-adhesion-vma-174705351.html January 1, 2015
http://prnewswire.com/news-releases/thrombogenics-and-bioinvent-to-regain-full-rights-to-tb-403-157132965.html May 5, 2015
http://prnewswire.co.uk/news-releases/thrombogenics-nv---business-update-177907291.html September 9, 2017
http://bio-medicine.org/biology-technology-1/thrombogenics-n-v--3a-business-update-8957-1 March 3, 2016
http://drugs.com/nda/ocriplasmin_120703.html January 1, 2015
http://br.sys-con.com/node/2500250 August 8, 2015
http://au.sys-con.com/node/2500250 August 8, 2015
http://devicespace.com/news/thrombogenics-ltd-announces-that-the-fda-intends/248212 January 1, 2015
http://biospace.com/News/thrombogenics-nv-novartis-ag-win-eu-ok-for-jetrea/285164 July 7, 2015
http://thestreet.com/story/11871593/1/thrombogenics-starts-trading-as-part-of-the-bel20-index-today.html May 5, 2017
http://prnewswire.com/news-releases/thrombogenics-founder-prof-desire-collen-receives-scrip-lifetime-achievement-award-233001071.html January 1, 2015
http://thestreet.com/story/11997501/4/germanys-iqwig-confirms-that-thrombogenics-jetrea-demonstrates-major-added-value-for-the-treatment-of-vitreomacular-traction-and-macular-hole.html March 3, 2016
http://prnewswire.com/news-releases/new-paper-in-cell-highlights-the-potential-role-of-tb-403-anti-plgf-in-the-treatment-of-medulloblastoma-a-pediatric-brain-tumor-194001881.html January 1, 2015
http://biospace.com/news/fda-advisory-committee-recommends-thrombogenics-nv/268285 May 5, 2017
http://drugs.com/clinical_trials/thrombogenics-presents-new-exciting-microplasmin-phase-iii-data-world-ophthalmology-congress-woc-9542.html January 1, 2015
http://prnewswire.com/news-releases/thrombogenics-and-bioinvent-complete-enrollment-of-phase-iib-trial-with-tb-402-ahead-of-schedule-135717238.html May 5, 2015
http://drugs.com/clinical_trials/thrombogenics-positive-microplasmin-phase-ii-data-published-ophthalmology-8845.html January 1, 2015
http://pr.gaeatimes.com/thrombogenics-and-bioinvent-complete-enrollment-of-phase-iib-trial-with-tb-402-ahead-of-schedule-54941 July 7, 2016
http://drugs.com/clinical_trials/microplasmin-meets-primary-endpoint-second-phase-iii-trial-vma-confirms-positive-findings-first-10028.html January 1, 2015
http://drugs.com/clinical_trials/thrombogenics-presents-positive-pooled-results-mivi-trust-phase-iii-program-confirming-microplasmin-10042.html April 4, 2015
http://bio-medicine.org/medicine-technology-1/thrombogenics-completes-patient-enrolment-in-us-phase-iii-trial-of-microplasmin-for-the-non-surgical-treatment-of-eye-disease-5051-1 August 8, 2017
http://bio-medicine.org/biology-technology-1/thrombogenics---positive-microplasmin-phase-ii-data-published-in-ophthalmology-15547-1 May 5, 2017
http://biospace.com/news/thrombogenics-ltd-and-bioinvent-complete/244042 February 2, 2015
http://drugs.com/clinical_trials/thrombogenics-announces-publication-positive-microplasmin-phase-ii-data-journal-retina-9825.html June 6, 2015
http://news.cision.com/se/bioinvent/r/positiva-resultat-fran-fas-ii-studie-av-tb-402-publicerade-i-journal-of-thrombosis-and-haemostasis,c546424 September 9, 2017
http://biospace.com/news_print.aspx July 7, 2015
http://prnewswire.com/news-releases/microplasmin-meets-primary-endpoint-in-second-phase-iii-trial-in-vma-confirms-positive-findings-of-first-trial-101948448.html September 9, 2017
http://bio-medicine.org/medicine-technology-1/thrombogenics-begins-phase-iii-program-with-microplasmin-for-the-non-surgical-treatment-of-back-of-the-eye-disease-3676-1 August 8, 2017
http://bio-medicine.org/medicine-technology-1/thrombogenics-announces-start-of-phase-ii-trial-of-microplasmin-for-the-treatment-of-age-related-macular-degeneration--28amd-29-6919-1 May 5, 2017
http://bio-medicine.org/medicine-technology-1/thrombogenics-completes-patient-enrolment-of-second-phase-iii-trial-of-microplasmin-for-the-non-surgical-treatment-of-eye-disease-7032-1 August 8, 2017
http://businesswire.com/news/home/20130228006146/en/bioinvent-paper-cell-highlights-potential-role-tb-403 March 3, 2016
http://prnewswire.com/news-releases/thrombogenics-opens-new-us-headquarters-141445613.html March 3, 2016
http://bio-medicine.org/biology-technology-1/thrombogenics-announces-business-update-and-2008-full-year-results-10968-1 March 3, 2016
http://thestreet.com/story/11572038/2/thrombogenics-receives-notice-from-fda-of-advisory-committee-meeting-for-ocriplasmin.html January 1, 2015
http://drugs.com/nda/ocriplasmin_120607.html March 3, 2016
http://biospace.com/news/thrombogenics-nv-completes-private-placement/254729 January 1, 2015
http://drugs.com/nda/ocriplasmin_111227.html March 3, 2016
http://au.sys-con.com/node/2464765 June 6, 2017
http://biospace.com/news_print.aspx May 5, 2015
http://au.sys-con.com/node/2500248 June 6, 2017
http://thestreet.com/story/11776730/3/jetrea-selected-for-single-technology-appraisal-sta-by-the-uks-national-institute-for-health-and-clinical-excellence-nice.html April 4, 2015
http://thestreet.com/story/11893576/5/thrombogenics-jetrea-the-first-and-only-medicine-for-treating-vitreomacular-traction-now-launched-in-the-uk.html May 5, 2015
http://biospace.com/collaborative/news/thromb-x-nv-opens-new-u-s-headquarters/251902 May 5, 2017
http://it.sys-con.com/node/2500250 January 1, 2015
http://biospace.com/news/thrombogenics-nv-novartis-ag-win-eu-ok-for-jetrea/285164/source=topbreaking January 1, 2015
http://in.sys-con.com/node/2464765 May 5, 2017
http://prnewswire.com/news-releases/us-fda-approves-thrombogenics-jetrea-ocriplasmin-for-the-treatment-of-symptomatic-vitreomacular-adhesion-vma-174705351.html January 1, 2015
http://prnewswire.com/news-releases/thrombogenics-and-bioinvent-to-regain-full-rights-to-tb-403-157132965.html May 5, 2015
http://uk.sys-con.com/node/2500248 March 3, 2016
http://bio-medicine.org/biology-technology-1/thrombogenics-nv-3a-business-update-12110-1 May 5, 2017
http://bio-medicine.org/biology-technology-1/thrombogenics-n-v--3a-business-update-8957-1 March 3, 2016
http://drugs.com/nda/ocriplasmin_120703.html January 1, 2015
http://br.sys-con.com/node/2500250 August 8, 2015
http://au.sys-con.com/node/2500250 August 8, 2015
http://devicespace.com/news/thrombogenics-ltd-announces-that-the-fda-intends/248212 January 1, 2015
http://biospace.com/News/thrombogenics-nv-novartis-ag-win-eu-ok-for-jetrea/285164 July 7, 2015
http://prnewswire.com/news-releases/thrombogenics-founder-prof-desire-collen-receives-scrip-lifetime-achievement-award-233001071.html January 1, 2015
http://thestreet.com/story/11997501/4/germanys-iqwig-confirms-that-thrombogenics-jetrea-demonstrates-major-added-value-for-the-treatment-of-vitreomacular-traction-and-macular-hole.html May 5, 2015
http://prnewswire.com/news-releases/new-paper-in-cell-highlights-the-potential-role-of-tb-403-anti-plgf-in-the-treatment-of-medulloblastoma-a-pediatric-brain-tumor-194001881.html January 1, 2015
http://thestreet.com/story/11530145/3/thrombogenics-nv--business-update.html March 3, 2016

Please log in to uncover the email addresses, access the 31 results for thrombogenics.com, filters and more.

Create a free account

Already have an account? Sign in

More information about thrombogenics.com

Language of the website: English

Find email addresses from any website

Search contact information of any website in one click.

When you visit a website, click on the icon to find the email addresses related to the website.